| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP And Chief Business Officer | See Remarks
1 company
Moore Matthew Richard is a SVP And Chief Business Officer at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $3.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SVP And Chief Business Officer | Sell | 4,681 | $8.74 | $40,901.64 | -3.1% | +17.1% | +77.2% | |
| Mar 4, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SVP And Chief Business Officer | Sell | 3,468 | $11.12 | $38,568.32 | -2.3% | -25.4% | +22.4% | |
| Mar 2, 2023 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 1,610 | $15.83 | $25,481.25 | -6.4% | -52.5% | -25.6% |